Apply Give

Other ways to search: Events Calendar | UTHSC

Continuing SGLT2 Inhibitors After Urinary Tract Infection

Written by Communications and Marketing

|

Discontinuation of SGLT2 inhibitors after developing UTI is associated with increased risk of cardiovascular and renal outcomes and overall increased mortality and does not decrease risk of recurrent UTIs. Dr. Tudor is an academic hospitalist at Erlanger Hospital and associate program director of the internal medicine residency program and associate professor of medicine at the University of Tennessee Health Science Center College of Medicine, both in Chattanooga, Tenn.

Top Publishers